Adding a PD-1 inhibitor to standard of care improved disease-free survival (DFS) in stage III soft-tissue sarcoma of the ...

Pembrolizumab, an immunotherapy medication, significantly enhanced disease-free survival when added to the standard of care ...

The EFTISARC-NEO trial, with a data cut-off of 20 October 2024, also showed 71.4% of patients achieved a pathologic response ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...

PITTSBURGH — Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...

James McMahon – Kerrang! Editor from 2011 to 2017 – has died from soft tissue sarcoma.

The findings, published today in The Lancet, establish pembrolizumab as a new option for patients with this disease. "Soft tissue sarcoma is a rare and complex disease with over 50 different ...

Immutep (IMMP) has released an update. Immutep Limited has announced promising results from its Phase II trial of eftilagimod alpha, combined ...

Tributes are being paid to former Kerrang! editor, music journalist and podcaster James McMahon, who passed away aged 44 on ...

Citation: Clinical trial shows immunotherapy drug pembrolizumab improves outcomes for patients with soft tissue sarcoma (2024, November 12) retrieved 15 November 2024 from https://medicalxpress ...